Pharmafile Logo
Pharmafocus logo
Advanced Search

cenobamate

Showing 1 posts of 1 posts found.

MHRA designates cenobamate as a Promising Innovative Medicine for treating drug resistant seizures

August 13, 2020
Research and Development MHRA, cenobamate, seizures

Arvelle Therapeutics has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has given their anti-seizure medication (cenobamate) …

News
The Gateway to Local Adoption Series

Latest content

Care Quality Commission appoints Emily Miles as Chief Executive

July 17, 2026

National survey aims to improve glaucoma care across the UK

July 16, 2026

Phase 3 trials support expanded use of Dysport for migraine prevention

July 15, 2026

Roche secures CE Mark for automated latent tuberculosis blood test

July 14, 2026

ReproNovo Phase 2 fertility study doses first participant

July 10, 2026